June 29, 2023 – Imugene presents new proof of concept data on stomach cancer vaccine at prestigious conference
Imugene Ltd (ASX:IMU, OTC:IUGNF) has presented new and significant data on HER-Vaxx at the World Congress of Gastrointestinal Cancer in Barcelona.
Read More>